Compass Therapeutics, Inc. Stock OTC Markets
Stocks
CMPX
US20454B1044
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Cboe BZX
11:19:17 2026-08-12 EDT
|
5-day change | 1st Jan Change | ||
| 2.195 USD | -38.17% |
|
+32.67% | - |
| Market Cap | 396M 343M 321M 293M 552M 37.79B 561M 3.77B 1.48B 18.91B 1.49B 1.46B 63.1B | P/E 2026 * |
-4.46x | P/E 2027 * | -4.15x |
|---|---|---|---|---|---|
| Enterprise Value | 246M 213M 200M 182M 343M 23.48B 349M 2.34B 918M 11.75B 924M 904M 39.21B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 11.3x |
| Free-Float |
87.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Compass Therapeutics, Inc.
| 1 day | -37.89% |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
CEO | Chief Executive Officer | 65 | 2024-05-27 |
Barry Shin
DFI | Director of Finance/CFO | 54 | 2024-12-08 |
Bing Gong
CTO | Chief Tech/Sci/R&D Officer | 50 | 2025-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
BRD | Director/Board Member | 65 | 2013-12-31 |
Phil Ferneau
BRD | Director/Board Member | 64 | 2014-12-31 |
Carl Gordon
CHM | Chairman | 61 | 2014-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -38.17% | +32.67% | - | - | 396M | |
| -0.73% | +12.52% | +74.33% | +102.34% | 70.51B | |
| +1.42% | +1.52% | +37.58% | +66.27% | 54.05B | |
| +1.50% | +35.43% | +9.92% | +501.35% | 28.95B | |
| -0.61% | +12.95% | +53.77% | +5.42% | 24.05B | |
| +0.11% | +1.01% | -16.11% | -13.33% | 23.31B | |
| -1.37% | +18.52% | +255.24% | +464.53% | 18.67B | |
| +2.21% | +7.45% | +46.89% | -19.80% | 18.37B | |
| 0.00% | +9.69% | +31.01% | +584.59% | 16.1B | |
| +0.32% | -9.22% | +35.63% | +139.28% | 12.72B | |
| Average | -3.51% | +9.36% | +58.69% | +203.40% | 29.64B | |
| Weighted average by Cap. | +0.23% | +10.21% | +56.44% | +167.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 23.35M 20.24M 18.94M 17.29M 32.53M 2.23B 33.08M 222M 87.03M 1.11B 87.68M 85.77M 3.72B |
| Net income | -93.55M -81.07M -75.9M -69.25M -130M -8.92B -133M -890M -349M -4.47B -351M -344M -14.9B | -105M -91.34M -85.51M -78.02M -147M -10.05B -149M -1B -393M -5.03B -396M -387M -16.79B |
| Net Debt | -150M -130M -122M -111M -209M -14.31B -212M -1.43B -559M -7.16B -563M -551M -23.89B | -133M -115M -108M -98.45M -185M -12.69B -188M -1.27B -496M -6.35B -499M -488M -21.18B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CMPX Stock
- CMPX Stock
Select your edition
All financial news and data tailored to specific country editions
